Pharmapark starts manufacturing veterinary medicines in Tallinn, Estonia for the international company Interchemie

The international veterinary pharmaceutical company Interchemie Werken De Adelaar Eesti AS is launching a cooperation with Pharmapark OÜ in Estonia. Under a manufacturing agreement, the Pharmapark factory located in Tallinn will begin supplying Interchemie with selected products, offered by Interchemie, starting from September 15, 2025.

This agreement will not affect Interchemie’s customers, and both companies are committed to the highest standards of quality and product safety. To ensure a smooth rollout, Interchemie will work closely with the relevant authorities in each market to guarantee compliance with regulatory regulations.

Pharmapark opened one of Europe’s largest and most modern veterinary medicine factories in Tallinn last year. The investment totaled 50 million euros, and the majority of production is intended for export.

In spring 2025, the Estonian State Agency of Medicines issued a Good Manufacturing Practice (GMP) certificate to Pharmapark Production OÜ’s chemical laboratory, confirming its compliance with EU regulatory requirements and the highest quality standards. This certification fully opens export markets for the Pharmapark factory and strengthens the company’s competitive position.

Certified laboratories provide Pharmapark with a strong foundation for further development of its quality system, supporting the production of sterile and aseptic medicines and ensuring compliance with the strictest regulatory requirements.